Results 211 to 220 of about 124,603 (293)

2-(2.6-DICHLOROPHENYLAMINO)-2-IMIDAZOLINE HYDROCHLORIDE (ST 155 OR CATAPRESAN) AS A PROPHYLACTIC REMEDY AGAINST MIGRAINE

, 1971
Ottar Sjaastad, Per Stensrud
openalex   +1 more source

Patient preferences for the preventive treatment of episodic migraine in the United States: A discrete‐choice experiment

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives This study was conducted among participants with episodic migraine, to (i) assess patient preferences for attributes associated with calcitonin gene‐related peptide‐targeting therapies to prevent migraine and (ii) predict the probability that a real‐world patient would prefer an atogepant‐like treatment profile over monoclonal ...
Richard B. Lipton, Pranav Gandhi, Kelley Myers, Cooper Bussberg, Jonathan Stokes, Stephanie J. Nahas   +5 more
wiley   +1 more source

Migraine and cochlear disease: A 2-sample bidirectional Mendelian randomized study. [PDF]

Medicine (Baltimore)
Zhong C, Wang LH, Dong Y, Zhang HP, Ji L, Guo Y.   +5 more
europepmc   +1 more source

Can serum neuropeptide levels help diagnose pediatric migraine? A prospective case–control study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective The objective of this study was to examine the serum levels of vasoactive neuropeptides (calcitonin gene‐related peptide [CGRP], pituitary adenylate cyclase‐activating peptide‐38 [PACAP‐38], substance P [SP], and vasoactive intestinal peptide [VIP], which have been linked to the pathophysiology of migraine in adults) in pediatric ...
Sibğatullah Ali Orak, Muzaffer Polat, Mert Pak, Çisil Çerçi Kubur, Aslı Kübra Atasever, Celil Yilmaz, Fatma Taneli, Ahmet Angin, Beyhan Cengiz Özyurt   +8 more
wiley   +1 more source

Shared neural signatures of photophobia in migraine and post-traumatic headache: a task-based fMRI study. [PDF]

J Headache Pain
Christensen RH, Al-Khazali HM, Melchior AG, Ashina M, Ashina H.   +4 more
europepmc   +1 more source

Identifying cognitive‐affective mechanisms underlying disability in episodic migraine: Using the fear avoidance model to examine interactions

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective Using the fear‐avoidance model (FAM) as a theoretical framework, this study examined the interactions between empirical factors contributing to disability in episodic migraine. It was tested whether pain catastrophizing, fear of attacks, and depressiveness mediate the relationship between pain experience and disability.
Janosch Fox, Charly Gaul, Merle Kuhlencord, Nicolina Peperkorn, Julia Ohse, Joshua Krutzki, Youssef Shiban   +6 more
wiley   +1 more source

What Is the Link Between Migraine and Hypothyroidism? A Systematic Literature Review. [PDF]

J Clin Med
Michalik M, Łapicka J, Sota M, Zawieska J, Grodzka O, Kępczyńska K.   +5 more
europepmc   +1 more source

Characterizing sleep, headache‐related disability, and psychological functioning among adolescents with continuous headache: A pilot study from a tertiary clinical setting

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objectives/Background Youth with continuous headache are understudied, are presumed to be more psychosocially complex and impaired than youth with remitting headache presentations, and are at risk for poor clinical outcomes. Given links between sleep and pain, characterizing sleep among youth with continuous headache may inform intervention ...
Ellie C. Adam, Robert C. Gibler, Dean W. Beebe, Scott W. Powers, Andrew D. Hershey, Marielle Kabbouche, Joanne Kacperski, Brooke L. Reidy   +7 more
wiley   +1 more source

Gepants in Primary Care: A Targeted Approach to Acute and Preventive Treatment of Migraine. [PDF]

Pain Ther
Moriarty MA, Barch CA.
europepmc   +1 more source

Effectiveness and tolerability of liraglutide as add‐on treatment in patients with obesity and high‐frequency or chronic migraine: A prospective pilot study

Headache: The Journal of Head and Face Pain, EarlyView.
Abstract Objective To assess whether glucagon‐like‐peptide‐1 receptor (GLP‐1R) agonists could serve as a novel prophylactic treatment for migraine in patients with obesity. Background Increased intracranial pressure (ICP) is speculated to play a role in migraine mechanisms, as chronic migraine and idiopathic intracranial hypertension without ...
Simone Braca, Cinzia Valeria Russo, Antonio Stornaiuolo, Gennaro Cretella, Angelo Miele, Caterina Giannini, Roberto De Simone   +6 more
wiley   +1 more source